Does LEVOMILNACIPRAN Cause Joint swelling? 143 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 143 reports of Joint swelling have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 10.4% of all adverse event reports for LEVOMILNACIPRAN.
143
Reports of Joint swelling with LEVOMILNACIPRAN
10.4%
of all LEVOMILNACIPRAN reports
137
Deaths
99
Hospitalizations
How Dangerous Is Joint swelling From LEVOMILNACIPRAN?
Of the 143 reports, 137 (95.8%) resulted in death, 99 (69.2%) required hospitalization, and 100 (69.9%) were considered life-threatening.
Is Joint swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LEVOMILNACIPRAN. However, 143 reports have been filed with the FAERS database.